The possibilities for AI in transforming oncology are immense. Consider the following examples that demonstrate the potential for groundbreaking advancements. Early Cancer Detection and Diagnosis: AI-powered…
I am thrilled to share that I have embarked on a new journey as the Director of Research and Innovation at the Southern California Cancer Center…
Breast cancer treatment often involves a multidisciplinary approach, with mastectomy and radiotherapy playing crucial roles in many cases. Individuals who have been diagnosed with breast cancer and need…
Ruxolitinib, a potent Janus kinase (JAK) family inhibitor, primarily targets JAK1 and JAK2. In the context of Large Granular Lymphocytic (LGL) Leukaemia, its mechanism of…
The FDA’s approval of alectinib (Alecensa) for adjuvant treatment in patients with ALK-positive non-small cell lung cancer (NSCLC) post-tumor resection marks a significant advancement in oncology care. Based…
Dr. Amir Ahari’s professional journey is a testament to his dynamic and forward-thinking approach as a physician-scientist. With over ten years of experience at the crossroads of…
This information will be used to contact you